(Q44969554)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15241836%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

title

Phase II study of high-dose fish oil capsules for patients with cancer-related cachexia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15241836%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15241836%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

9

Electra Paskett

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15241836%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

author name string

C Patrick Burns

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15241836%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Gerald Clamon

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15241836%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Ellen Kaplan

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15241836%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Raymond J Hohl

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15241836%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

James N Atkins

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15241836%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Michael A Schwartz

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15241836%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Brett A Wagner

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15241836%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

language of work or name

English

0 references

publication date

1 July 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15241836%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15241836%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

volume

101

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15241836%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15241836%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

page(s)

370-378

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15241836%20AND%20SRC:MED&resulttype=core&format=json

Effect of a tumour-derived lipid-mobilising factor on glucose and lipid metabolism in vivo.

30 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20362

7 January 2021

Characterization of a cancer cachectic factor

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20362

7 January 2021

Effect of fish oil on cancer cachexia and host liver metabolism in rats with prostate tumors.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20362

7 January 2021

Effect of oral eicosapentaenoic acid on weight loss in patients with pancreatic cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20362

7 January 2021

Dietary omega-3 polyunsaturated fatty acids plus vitamin E restore immunodeficiency and prolong survival for severely ill patients with generalized malignancy: a randomized control trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20362

7 January 2021

Effect of fish oil on appetite and other symptoms in patients with advanced cancer and anorexia/cachexia: a double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20362

7 January 2021

Effect of a protein and energy dense N-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: a randomised double blind trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20362

7 January 2021

Re-validation and shortening of the Functional Assessment of Anorexia/Cachexia Therapy (FAACT) questionnaire

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20362

7 January 2021

Nutritional and metabolic assessment of the hospitalized patient

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20362

7 January 2021

Plasma and neutrophil fatty acid composition in advanced cancer patients and response to fish oil supplementation.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20362

7 January 2021

Effects of medroxyprogesterone acetate on appetite, weight, and quality of life in advanced-stage non-hormone-sensitive cancer: a placebo-controlled multicenter study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20362

7 January 2021

Megestrol acetate for anorexia in patients with far-advanced cancer: a double-blind controlled clinical trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20362

7 January 2021

Controlled trial of megestrol acetate for the treatment of cancer anorexia and cachexia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20362

7 January 2021

A controlled trial of megestrol acetate on appetite, caloric intake, nutritional status, and other symptoms in patients with advanced cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20362

7 January 2021

Body-composition changes in patients who gain weight while receiving megestrol acetate

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20362

7 January 2021

The effect of an oral nutritional supplement enriched with fish oil on weight-loss in patients with pancreatic cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20362

7 January 2021